Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS)
CNY 19.91
(1.01%)
CNY 19.91
(1.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -84.06 Million | -70.35 Million | -23.59 Million | 146.9 Million | 216.62 Million | 143.64 Million |
| Net Income | 121.24 Million | 104.42 Million | 68.49 Million | 114.48 Million | 168.32 Million | 109.33 Million |
| Depreciation & Amortization | 112.42 Million | 94.25 Million | 69.53 Million | 62.98 Million | 60.34 Million | 57.37 Million |
| Deferred income taxes | 167.56 Thousand | -1.73 Million | -3.76 Million | -1.52 Million | -367.2 Thousand | -213.5 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -341.93 Million | -265.51 Million | -172.1 Million | -34.75 Million | -23.07 Million | -42.46 Million |
| Other non-cash items | 4.56 Million | -3.51 Million | 10.48 Million | 4.19 Million | 11.03 Million | 19.39 Million |
| Investing Cash Flow | -334.56 Million | -63.98 Million | -334.2 Million | -50.56 Million | -56.99 Million | -28.62 Million |
| Investments in PPE | -227.47 Million | -87.81 Million | -121.97 Million | -61.08 Million | -57.78 Million | -29.47 Million |
| Acquisitions | 2.28 Million | 2.32 Million | 5.37 Million | 10.51 Million | 658.4 Thousand | 847.9 Thousand |
| Investment purchases | -265.5 Million | -175 Million | -566 Million | - | -658.4 Thousand | - |
| Sales/Maturities of investments | 156.11 Million | 196.51 Million | 348.39 Million | - | 130 Thousand | - |
| Other Investing Activities | -107.09 Million | 1.20 | 1.39 | 0.54 | 658.35 Thousand | 847.87 Thousand |
| Financing Cash Flow | 617.01 Million | 88.47 Million | -54.11 Million | 744.45 Million | -138.37 Million | -189.29 Million |
| Debt repayment | -42.23 Million | -2 Million | -12 Million | -51.5 Million | -118.5 Million | -289 Million |
| Dividends payments | -32.94 Million | -22.72 Million | -39.76 Million | -15.33 Million | -64.87 Million | -8.01 Million |
| Common Stock Repurchased | -30 Million | - | 1.48 Million | 44.03 Million | - | - |
| Common Stock Issuance | - | - | -1.48 Million | -44.03 Million | - | - |
| Other Financing Activities | 611.03 Million | 113.84 Million | -3.07 Million | 814.4 Million | 45 Million | 107.72 Million |
| Accounts receivables | -54.33 Million | -246.17 Million | -12.58 Million | -84.23 Million | 13.04 Million | 47.63 Million |
| Accounts payables | -138.8 Million | 45.43 Million | 2.7 Million | 31.19 Million | -45.4 Million | -16.45 Million |
| Inventory | -148.96 Million | -63.04 Million | -158.47 Million | 19.81 Million | 9.65 Million | -73.42 Million |
| Other working capital | 9.49 Million | -1.73 Million | -3.76 Million | -1.52 Million | -367.13 Thousand | 30.95 Million |
| Cash at beginning of period | 501.58 Million | 547.21 Million | 959.42 Million | 118.95 Million | 96.97 Million | 171.46 Million |
| Cash at end of period | 700.95 Million | 501.58 Million | 547.21 Million | 959.42 Million | 118.95 Million | 96.97 Million |
| Capital Expenditure | -227.47 Million | -87.81 Million | -121.97 Million | -61.08 Million | -57.78 Million | -29.47 Million |
| Effect of forex changes on cash | 988.42 Thousand | 222.64 Thousand | -292.49 Thousand | -316.69 Thousand | 724.61 Thousand | -225.97 Thousand |
| Net cash flow / Change in cash | 199.37 Million | -45.62 Million | -412.21 Million | 840.47 Million | 21.98 Million | -74.49 Million |
| Free Cash Flow | -311.53 Million | -158.17 Million | -145.57 Million | 85.82 Million | 158.84 Million | 114.17 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 12.69 Million | 8.43 Million | 24.03 Million | 121.24 Million | 35.68 Million | 30.95 Million |
| Depreciation & Amortization | - | 34.43 Million | 34.43 Million | 112.42 Million | 29.51 Million | 29.51 Million |
| Deferred income taxes | - | - | - | 167.56 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -165.66 Million | - | -341.93 Million | -193.8 Million | - |
| Other non-cash items | -11.95 Million | 4.55 Million | -121.12 Million | 4.56 Million | 7.77 Million | -35.08 Million |
| Investing Cash Flow | -49.88 Million | -250.7 Million | 18.27 Million | -334.56 Million | -188.28 Million | -53.07 Million |
| Investments in PPE | -47.01 Million | -68.79 Million | -36.44 Million | -227.47 Million | -79.68 Million | -48.82 Million |
| Acquisitions | 195.35 Thousand | 149.89 Thousand | 402.98 Thousand | 2.28 Million | 832.64 Thousand | 1.01 Million |
| Investment purchases | -180 Million | -459.4 Million | -100 Million | -265.5 Million | -140 Million | -30.5 Million |
| Sales/Maturities of investments | 180 Million | 275 Million | 156.66 Million | 156.11 Million | 30.56 Million | 25.22 Million |
| Other Investing Activities | -3.07 Million | 2.52 Million | -2.34 Million | -107.09 Million | -108.6 Million | 1.02 |
| Financing Cash Flow | 20.68 Million | -82.4 Million | 43.4 Million | 617.01 Million | -91.52 Million | 616.96 Million |
| Debt repayment | -10 Million | -80 Million | -119.5 Million | -42.23 Million | -90.26 Million | -7 Million |
| Dividends payments | - | -36.77 Million | -600.69 Thousand | -32.94 Million | -32.94 Million | -2.88 Million |
| Common Stock Repurchased | 25 Million | -25 Million | - | -30 Million | -30 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 5.68 Million | 111.16 Million | -75.49 Million | 611.03 Million | -551.89 Thousand | 626.84 Million |
| Accounts receivables | - | -109.19 Million | - | -54.33 Million | -54.33 Million | - |
| Accounts payables | - | - | - | -138.8 Million | - | - |
| Inventory | - | -72.68 Million | - | -148.96 Million | -148.96 Million | - |
| Other working capital | - | 16.22 Million | - | 9.49 Million | 9.49 Million | - |
| Cash at beginning of period | 312.23 Million | 676.12 Million | 700.95 Million | 501.58 Million | 966.62 Million | 406.31 Million |
| Cash at end of period | 293.97 Million | 312.23 Million | 665.95 Million | 700.95 Million | 700.95 Million | 966.62 Million |
| Capital Expenditure | -47.01 Million | -68.79 Million | -36.44 Million | -227.47 Million | -79.68 Million | -48.82 Million |
| Effect of forex changes on cash | - | 835.11 Thousand | 408.46 Thousand | 988.42 Thousand | 339.56 Thousand | 558.2 Thousand |
| Net cash flow / Change in cash | -18.26 Million | -363.88 Million | -35 Million | 199.37 Million | -265.66 Million | 560.31 Million |
| Free Cash Flow | -46.27 Million | -90.24 Million | -133.53 Million | -311.53 Million | -65.73 Million | -52.95 Million |
300085
8897
KLSVF
6278
KKO
2769